drugset / Trial / NCT00125801

The Pain Pen for Breakthrough Cancer Pain

NCT00125801

Phase 3 Terminated 50 enrolled Erasmus Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine.

Timeline

Start
2005-08
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified Subcutaneous

Indications